These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17150311)
1. Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders. Bradstreet JJ; Smith S; Granpeesheh D; El-Dahr JM; Rossignol D Med Hypotheses; 2007; 68(5):979-87. PubMed ID: 17150311 [TBL] [Abstract][Full Text] [Related]
2. Use of spironolactone in dermatology. Rathnayake D; Sinclair R Skinmed; 2010; 8(6):328-32; quiz 333. PubMed ID: 21413648 [TBL] [Abstract][Full Text] [Related]
3. Effect of spironolactone on C-reactive protein levels in patients with heart disease. Godfrey V; Farquharson CA; Macdonald JE; Yee KM; Struthers AD Int J Cardiol; 2007 Apr; 117(2):282-4. PubMed ID: 16899309 [TBL] [Abstract][Full Text] [Related]
4. [No effect of spironolactone on bulimia nervosa symptoms]. von Wietersheim J; Müller-Bock V; Rauh S; Danner B; Chrenko K; Bühler G Psychother Psychosom Med Psychol; 2008 Dec; 58(12):470-4. PubMed ID: 18666040 [TBL] [Abstract][Full Text] [Related]
5. A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders. Geier DA; Geier MR Neuro Endocrinol Lett; 2006 Dec; 27(6):833-8. PubMed ID: 17187010 [TBL] [Abstract][Full Text] [Related]
6. Nicotinic cholinergic antagonists: a novel approach for the treatment of autism. Lippiello PM Med Hypotheses; 2006; 66(5):985-90. PubMed ID: 16406687 [TBL] [Abstract][Full Text] [Related]
8. [Hormonal treatments of acne]. Faure M; Drapier-Faure E Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 2):142-7. PubMed ID: 12605145 [No Abstract] [Full Text] [Related]
9. Clinical experience with spironolactone in pediatrics. Buck ML Ann Pharmacother; 2005 May; 39(5):823-8. PubMed ID: 15811903 [TBL] [Abstract][Full Text] [Related]
10. Hormonal therapy for acne. George R; Clarke S; Thiboutot D Semin Cutan Med Surg; 2008 Sep; 27(3):188-96. PubMed ID: 18786497 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic expression of autoimmune autistic disorder (AAD): a major subset of autism. Singh VK Ann Clin Psychiatry; 2009; 21(3):148-61. PubMed ID: 19758536 [TBL] [Abstract][Full Text] [Related]
12. [The treatment of hirsutism in adolescent girls with spironolactone]. Malinova M Akush Ginekol (Sofiia); 1999; 38(4):28-30. PubMed ID: 10726349 [TBL] [Abstract][Full Text] [Related]
13. Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism. Rossignol DA Med Hypotheses; 2007; 68(6):1208-27. PubMed ID: 17141962 [TBL] [Abstract][Full Text] [Related]
14. [What is the role of hormonal treatments in acne?]. Drapier-Faure E; Faure M Ann Dermatol Venereol; 2001 Apr; 128 Supp 1():S19-24; discussion S33. PubMed ID: 11450396 [No Abstract] [Full Text] [Related]
15. Identification and evaluation of children with autism spectrum disorders. Johnson CP; Myers SM; Pediatrics; 2007 Nov; 120(5):1183-215. PubMed ID: 17967920 [TBL] [Abstract][Full Text] [Related]
16. Novel treatments for autistic spectrum disorders. Levy SE; Hyman SL Ment Retard Dev Disabil Res Rev; 2005; 11(2):131-42. PubMed ID: 15977319 [TBL] [Abstract][Full Text] [Related]
17. The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Geier MR; Geier DA Med Hypotheses; 2005; 64(5):946-54. PubMed ID: 15780490 [TBL] [Abstract][Full Text] [Related]
18. Behaviors associated with fever in children with autism spectrum disorders. Curran LK; Newschaffer CJ; Lee LC; Crawford SO; Johnston MV; Zimmerman AW Pediatrics; 2007 Dec; 120(6):e1386-92. PubMed ID: 18055656 [TBL] [Abstract][Full Text] [Related]
19. The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders. Bransfield RC; Wulfman JS; Harvey WT; Usman AI Med Hypotheses; 2008; 70(5):967-74. PubMed ID: 17980971 [TBL] [Abstract][Full Text] [Related]
20. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker. Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]